Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
Fox Chase Cancer Center /Inc/
Search grants from Fox Chase Cancer Center /Inc/
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular Basis of Multidrug Binding and Transport by the MATE Transporters
Pulmonary Effects of Habitual Use of Marijuana
CDK3 and Cell Cycle Regulation
Basis of Polar Solvent Therapy of Colon Cancer Cells
Selective Inhibitors of Placental Steroid Aromatase
Recently added grants:
Enduring effects of juvenile ketamine exposure
Data Coord Ctr-NICHD Cooperative Multicenter Maternal Medicine Units Research Net
Luna International Indigenous Health Research Training Program
Examining the role of pregnancy coverage in preventing poor obstetric outcomes among Latina immigrants
Imaging neural dynamics at high temporal resolution in sleep and sleep deprivation
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN025120-003
Application #
7191429
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center /Inc/
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2005
N01 CN
Phase I Single and Multiple-Dose Safety and Pharmacokinetic and Drug -261025120
/ Fox Chase Cancer Center /Inc/
NIH 2004
N01 CN
Phase I. in Vivo and IN Vitro Pharmacology of A Chemopreventive Agent -261025120
/ Fox Chase Cancer Center /Inc/
Comments
Be the first to comment on this grant